Hundreds of ophthalmologists gather in Washington, D.C., for Mid-Year Forum 2025, April 2-5. Follow our ongoing coverage here.
Hundreds of Academy members are in Washington, D.C., for Mid-Year Forum 2025, meeting with members of Congress and discussing pressing legislative issues. See what they're saying.
Related Stories
Member exclusive - Locked
Advocacy at Home: August Recess 2026 Sign-Up Form
Congress heads home in August, and the timing could not be more important. Prior authorization reform and Medicare physician payment reform are both in play this fall — and constituent meetings during recess are one of the most effective ways to move legislators off the sidelines. The Academy will coordinate the meeting; you bring the message.
Mid-Year Forum 2026 Live Coverage
Hundreds of ophthalmologists gather in Washington, D.C., for Mid-Year Forum 2026, April 15-18. Follow our ongoing coverage here.
Member exclusive - Locked
Join the OPHTHPAC® March Mayhem State Challenge
Advocacy wins don’t happen by accident — they happen because members like you step up. Make your OPHTHPAC contribution today to enter this spirited competition and help your state lead the nation in advocacy strength.
Milestone Moment: Seniors' Act Advances Unanimously Through Ways & Means Committee
Thanks to Academy advocacy and leadership, and the voices of members like you, the Seniors’ Act cleared a major hurdle in reforming prior authorization in Medicare Advantage. Let’s keep pushing until it becomes law.
Member exclusive - Locked
2027 Fee Schedule Proposes Cutting Pay to Physicians by 1.68%
The Centers for Medicare & Medicaid Services (CMS) has released its proposed Medicare Physician Fee Schedule for 2027. Here are the highlights based on the Academy’s analysis. The Academy will work with our advocacy partners to ensure finalized policies support our members and their patients.
Member exclusive - Locked
Academy Rallies Ophthalmology to Fight Proposed Drug-delivery Coverage Cuts
Leading the profession's response, the Academy united ophthalmic societies to formally oppose Medicare's proposed restrictions on intraocular drug-delivery implant coverage.
